• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aug 10 Third H1N1 death in state of Georgia (US) confirmed

bcgauspohl

Active member
Third H1N1 death in state of Georgia (US) confirmed

WFXL Ch 31
Monday, August 10, 2009 at 3:07 p.m.

An Albany area man in his 60s is the first patient in the Southwest Health District?s 14 counties and the third resident of Georgia who has died from Pandemic H1N1, says Southwest Health District Health Director Dr. Jacqueline Grant.

"With great sorrow, we acknowledge complications from the novel influenza virus H1N1 have claimed the life of a member of our community," said Grant. "We offer our sympathy to the individual?s loved ones."

The older adult had underlying health conditions and had been hospitalized prior to his death on Friday, she said.

No other patients in the District are currently hospitalized with confirmed cases of H1N1, noted Grant, although nine hospitalizations (including the deceased patient), have occurred since the infection began spreading through Georgia earlier this year. A Cobb County woman who died in July was the state?s first fatality linked to H1N1. Late last week, another Cobb County resident became the state?s second confirmed H1N1 fatality.

"We have been concerned that this infection could result in severe illness, particularly in high-risk groups, which include children, pregnant women and people with compromised immune systems or chronic diseases," said Grant. "We cannot emphasize enough how important it is for everyone to practice cough and sneezing etiquette, to wash your hands thoroughly and to stay home if you are sick. Taking these three actions are our best protection to keep H1N1 from spreading."

Once seasonal flu vaccine becomes available, it will also play a key role in combating the pandemic?s spread, she added.

"We are expecting the seasonal flu vaccine to be out earlier than usual this year, maybe as early as late this month or early September," Grant said. "As soon as it is available, we recommend people begin getting vaccinated."

A vaccine for H1N1 is unlikely to be ready until mid-October at the earliest, she said.

http://www.mysouthwestga.com/news/story_print.aspx?id=335241&type=story
 
Re: Aug 10 Third H1N1 death in state of Georgia (US) confirmed

Comparisons between BARDA (Biomedical Advance Research and Development Authority) of the US Department of Health and Human Services and DARPA (Defense Advanced Research Projects Agency) of the Pentagon/US Department of Defense:

Other participants viewed BARDA as a biomedical equivalent of the Defense Advanced Research Projects Agency (DARPA), with autonomous program managers. A BARDA program manager could be responsible for a given threat, with a portfolio of countermeasures in various stages of development. Autonomous program managers could help smaller biotech companies, which do not have the capital to wait through long delays and can be ?killed by slow committee decisions.?

One participant suggested that program managers fund some products up to an advanced stage, but not fully to licensure. These advanced-stage products would then be ?mothballed? for future use during an emergency, or if other products selected for further development fail in later-stage testing.

What???
 
Back
Top